Dino Vaira

Azienda USL di Bologna — Italy

Medicine · Health Sciences

39h-index5.5kcitations196works6.82yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Helicobacter pylori-related gastroenterology studies(168), Gastric Cancer Management and Outcomes(57), Gastroesophageal reflux and treatments(48), Eosinophilic Esophagitis(40), Veterinary medicine and infectious diseases(38)

Publications196 total

Why internists should care about Helicobacter pylori: recapitulating gastric cancer prevention
Internal and Emergency Medicine·2025
Understanding the epidemiology of gastric cancer: a review and case-only analysis from Italy
European Journal of Gastroenterology & Hepatology·2025
Updating Primary Antibiotic Resistance in Helicobacter pylori Strains Isolated in Italy
Journal of Gastrointestinal and Liver Diseases·2024· 1 citedOpen Access
Diverticulosis, Adenomas, and Cancer in the Colon
Journal of Clinical Gastroenterology·2024· 1 cited
Role of compliance in <i>Helicobacter pylori</i> eradication treatment: Results of the European Registry on <i>H. pylori</i> management
United European Gastroenterology Journal·2024· 32 citedOpen Access
Role of proton pump inhibitors dosage and duration in <i>Helicobacter pylori</i> eradication treatment: Results from the European Registry on <i>H. pylori</i> management
United European Gastroenterology Journal·2023· 19 citedOpen Access
Author Correction: Comparison of the management of Helicobacter pylori infection between the older and younger European populations
Scientific Reports·2023· 2 citedOpen Access
Comparison of the management of Helicobacter pylori infection between the older and younger European populations
Scientific Reports·2023· 12 citedOpen Access
Analysis of Clinical Phenotypes through Machine Learning of First-Line H. pylori Treatment in Europe during the Period 2013–2022: Data from the European Registry on H. pylori Management (Hp-EuReg)
Antibiotics·2023· 8 citedOpen Access
Helicobacter pylori Diagnostic Tests Used in Europe: Results of over 34,000 Patients from the European Registry on Helicobacter pylori Management
Journal of Clinical Medicine·2023· 15 citedOpen Access
Helicobacter pylori eradication and aspirin: a puzzle yet to be solved
The Lancet·2023Open Access
140 - TRATAMIENTO ERRADICADOR DE SEXTA LÍNEA FRENTE A HELICOBACTER PYLORI: DATOS PRELIMINARES DEL REGISTRO EUROPEO SOBRE EL MANEJO DE LA INFECCIÓN POR HELICOBACTER PYLORI (HP-EUREG)
Gastroenterología y Hepatología·2023
135 - TENDENCIAS DE PRESCRIPCIÓN DE TRATAMIENTOS ERRADICADORES Y DE SU EFECTIVIDAD EN PACIENTES NAÏVE A LO LARGO DE 10 AÑOS (2013-2022) EN EUROPA: DATOS DEL REGISTRO EUROPEO SOBRE EL MANEJO DE LA INFECCIÓN POR HELICOBACTER PYLORI (HP-EUREG)
Gastroenterología y Hepatología·2023
130 - COMPARACIÓN DE LA EFECTIVIDAD DE LOS TRATAMIENTOS ERRADICADORES MÁS FRECUENTES ENTRE LAS POBLACIONES MÁS MAYORES Y MÁS JÓVENES DE EUROPA: DATOS DEL REGISTRO EUROPEO SOBRE EL MANEJO DE LA INFECCIÓN POR HELICOBACTER PYLORI (HP-EUREG)
Gastroenterología y Hepatología·2023
123 - OPTIMIZACIÓN DE LA DOSIS DE LOS INHIBIDORES DE LA BOMBA DE PROTONES EN LOS TRATAMIENTOS ERRADICADORES DE PRIMERA Y SEGUNDA LÍNEA FRENTE A HELICOBACTER PYLORI: RESULTADOS DEL REGISTRO EUROPEO SOBRE EL MANEJO DE LA INFECCIÓN POR HELICOBACTER PYLORI (HP-EUREG)
Gastroenterología y Hepatología·2023
Efficacy of a new nutraceutical formulation: L-tryptophan, probiotics, charcoal, chamomile, mint, and licorice (COLONIR®) in the improvement of gastrointestinal symptoms in subjects with irritable bowel syndrome
Minerva Gastroenterology·2023· 4 cited
Effectiveness of first and second‐line empirical treatment in Italy: Results of the European registry on <i>Helicobacter pylori</i> management
United European Gastroenterology Journal·2022· 17 citedOpen Access
Empirical rescue treatment of <i>Helicobacter pylori</i> infection in third and subsequent lines: 8-year experience in 2144 patients from the European Registry on <i>H. pylori</i> management (Hp-EuReg)
Gut·2022· 10 cited
Experience with Rifabutin-Containing Therapy in 500 Patients from the European Registry on Helicobacter pylori Management (Hp-EuReg)
Journal of Clinical Medicine·2022· 24 citedOpen Access
Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg)
Clinical Gastroenterology and Hepatology·2021· 39 citedOpen Access
page 1 of 10Next →

Frequent Co-authors

Angelo Zullo(17), Giulia Fiorini(14), Ilaria Maria Saracino(12), Cesare Hassan(10), Luigi Gatta(10), Françis Mégraud(9), Antonio Gasbarrini(9), Vincenzo De Francesco(9), Nimish Vakil(8), Javier P. Gisbert(8), Chiara Ricci(7), Olga P. Nyssen(6), Peter Malfertheiner(5), Д.С. Бордин(5), Bojan Tepeš(5), Manuel Castro‐Fernández(5), Luı́s Rodrigo(5), Federico Perna(5), Colm O’Morain(5), Valentina Castelli(5)